Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaoyang Teng

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|March 14, 2017
Unified additional requirement in consideration of regional approval for multiregional clinical trialsZhaoyang Teng, Yeh-Fong Chen, Mark Chang
Statistics in Medicine|April 28, 2020
Seamless phase 2/3 oncology trial design with flexible sample size determinationZhaoyang Teng, Yuan Tian, Yi Liu, et al.
Statistics in Medicine|August 8, 2018
Optimal seamless phase 2/3 oncology trial designs based on Probability of Success (PoS)Zhaoyang Teng, Liang Liang, Guohui Liu, et al.
Journal of Biopharmaceutical Statistics|April 23, 2025
An improved biomarker-guided adaptive patient enrichment design for oncology trialsZhenwei Zhou, Zhaoyang Teng, Jian Zhu, et al.
Pharmaceutical Statistics|July 2, 2024
Futility Interim Analysis Based on Probability of Success Using a Surrogate EndpointRonan Fougeray, Loïck Vidot, Marco Ratta, et al.
Clinical and Translational Science|November 24, 2017
Model-Based Meta-Analysis for Multiple Myeloma: A Quantitative Drug-Independent Framework for Efficient Decisions in Oncology Drug DevelopmentZhaoyang Teng, Neeraj Gupta, Zhaowei Hua, et al.
Japanese Journal of Clinical Oncology|November 22, 2022
Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a randomized phase 2 trialJunji Furuse, Makoto Ueno, Masafumi Ikeda, et al.
Future Oncology (London, England)|June 10, 2025
Indirect treatment comparison of ivosidenib and other therapies in patients with newly diagnosed acute myeloid leukemiaManuel David Gil-Sierra, Theo Mantopoulos, Ifigeneia Barouma, et al.
Journal of the American Heart Association|July 18, 2017
Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart StudyJustin P Zachariah, Rene Quiroz, Kerrie P Nelson, et al.
Clinical Endocrinology|August 21, 2012
Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart StudyRobin Haring, Zhaoyang Teng, Vanessa Xanthakis, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|March 14, 2017
Unified additional requirement in consideration of regional approval for multiregional clinical trialsZhaoyang Teng, Yeh-Fong Chen, Mark Chang
Statistics in Medicine|April 28, 2020
Seamless phase 2/3 oncology trial design with flexible sample size determinationZhaoyang Teng, Yuan Tian, Yi Liu, et al.
Statistics in Medicine|August 8, 2018
Optimal seamless phase 2/3 oncology trial designs based on Probability of Success (PoS)Zhaoyang Teng, Liang Liang, Guohui Liu, et al.
Journal of Biopharmaceutical Statistics|April 23, 2025
An improved biomarker-guided adaptive patient enrichment design for oncology trialsZhenwei Zhou, Zhaoyang Teng, Jian Zhu, et al.
Pharmaceutical Statistics|July 2, 2024
Futility Interim Analysis Based on Probability of Success Using a Surrogate EndpointRonan Fougeray, Loïck Vidot, Marco Ratta, et al.
Clinical and Translational Science|November 24, 2017
Model-Based Meta-Analysis for Multiple Myeloma: A Quantitative Drug-Independent Framework for Efficient Decisions in Oncology Drug DevelopmentZhaoyang Teng, Neeraj Gupta, Zhaowei Hua, et al.
Japanese Journal of Clinical Oncology|November 22, 2022
Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a randomized phase 2 trialJunji Furuse, Makoto Ueno, Masafumi Ikeda, et al.
Future Oncology (London, England)|June 10, 2025
Indirect treatment comparison of ivosidenib and other therapies in patients with newly diagnosed acute myeloid leukemiaManuel David Gil-Sierra, Theo Mantopoulos, Ifigeneia Barouma, et al.
Journal of the American Heart Association|July 18, 2017
Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart StudyJustin P Zachariah, Rene Quiroz, Kerrie P Nelson, et al.
Clinical Endocrinology|August 21, 2012
Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart StudyRobin Haring, Zhaoyang Teng, Vanessa Xanthakis, et al.
Pageof 2